FDA Releases Final Guidance on Characterization of Cell Substrates and Bio Materials for Viral Vaccines

Source: PharmaManufacturing.com

Mar 03, 2010

FDA has released finalized, nonbinding guidance on the characterization and qualification of cell substrates and biologicial materials used in the production of viral vaccines.

A critical section for manufacturers regards testing at different stages of production, from cell banks and pre-production cells to final filled product. The guidance also contains descriptions of test methods for adventitious agents and cell properties.

Click here to view.

 

 

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments